Cargando…
Assessment of Oncologists’ Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor–Positive Breast Cancer
IMPORTANCE: Randomized clinical trial data have demonstrated that omission of surgical axillary evaluation does not affect overall survival in women 70 years and older with early-stage (clinical tumor category 1 [cT1] with node-negative [N0] disease) hormone receptor (HR)–positive and erb-B2 recepto...
Autores principales: | Minami, Christina A., Bryan, Ava F., Freedman, Rachel A., Revette, Anna C., Schonberg, Mara A., King, Tari A., Mittendorf, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403774/ https://www.ncbi.nlm.nih.gov/pubmed/36001314 http://dx.doi.org/10.1001/jamanetworkopen.2022.28524 |
Ejemplares similares
-
Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023) -
Sentinel lymph node biopsy in breast cancer
por: Alsaif, Abdulaziz A.
Publicado: (2015) -
Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008) -
Sentinel lymph node biopsies in breast cancer
por: Hess, A, et al.
Publicado: (2001) -
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)